Research Core Director: Douglas Spitz, PhD

RS Co-Director: Dr. Prabhat C. Goswami
EPR Co-Director: Dr. Garry R. Buettner

Recent evidence indicates that oxidation/reduction (redox) reactions are disrupted in cancer vs. normal cells as well as by cancer therapy interventions and these biochemical alterations significantly contribute to outcomes in a host of human diseases. The goal of the Radiation and Free Radical Research Core (RFRRC) is to provide state of the art technologies to investigators studying the role of oxidative stress and redox biology as they relate to cancer biology and cancer therapy in order to aid in the development of novel biochemical rationales for improving cancer prevention and therapy as well as studying degenerative diseases associated with aging.

The Radiation and Free Radical Research Core focuses on providing state of the art technologies to investigators studying the role of oxidative stress and redox biology. There is growing evidence that oxidative stress and redox biology are critical determinants of cancer biology including the processes of initiation, promotion, and progression to malignancey as well as the prevention and treatment of cancer and degenerative diseases of aging. The RFRRC was established to provide easy access to free radical and radiation biology expertise, reagents, technologies, and analysis for investigators doing basic, pre-clinical, and clinical research. The RFRRC offers the following three basic services to the university community and to researchers and private companies across the country: